MediPal Holdings Corporation (7459)

Name: MediPal Holdings Corporation (7459) — histórico de demonstrações financeiras
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

Histórico de receita, lucros e fluxo de caixa das demonstrações financeiras oficiais.

Healthcare · Wall Street (EUA) · Última atualização: 2026-10-02

MediPal Holdings Corporation engages in the prescription pharmaceutical wholesale business in Japan. The company engages in the manufacture and supply of medical drugs, medical devices, medical supplies, clinical test reagents, and medical equipment and materials; non-life insurance agency business; outsourcing of medical office administration services; research and development of preventive medicine and cutting-edge medical technologies; and construction of a medical materials database.

Números-chave

Capitalização de mercado: JPY 598 billion
Receita (exercício encerrado em 2026-03-31): JPY 3.82T
Lucro líquido: JPY 42.5B
Margem bruta: 6.8%
Margem líquida: 1.1%

Ver gráficos interativos e demonstrações completas → Modelo de avaliação (DCF) →

Demonstração de resultados anual

Demonstração de resultados	2026-03-31	2025-03-31	2024-03-31	2023-03-31
Receita total	JPY 3.82T	JPY 3.67T	JPY 3.56T	JPY 3.36T
Lucro bruto	JPY 261.0B	JPY 255.8B	JPY 246.7B	JPY 224.3B
Resultado Operacional (EBIT)	JPY 53.2B	JPY 55.6B	JPY 47.3B	JPY 49.0B
Resultado líquido	JPY 42.5B	JPY 40.3B	JPY 41.5B	JPY 38.8B

Fonte: relatórios públicos da empresa (SEC). Verifique no SEC EDGAR antes de confiar em qualquer número.

Balanços, fluxos de caixa, dados trimestrais e indicadores completos no visualizador interativo de 7459. /companies/us/7459

Empresas semelhantes

As informações deste site são apenas educacionais e informativas; não constituem recomendação de investimento. Não publicamos preços-alvo nem recomendações.

English version →Todas as ações

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.